Xometry Insider Sale: CFO Disposes 598 Class A Shares via 10b5-1 Plan

Rhea-AI Filing Summary

Xometry, Inc. (XMTR) insider sale summarized The company's Chief Financial Officer, James Miln, reported selling a total of 598 shares of Class A common stock on 09/02/2025 under a pre-established Rule 10b5-1 trading plan. The sales were executed in multiple transactions with weighted-average prices of $49.7241 and $50.5207, with price ranges disclosed in the filing.

After the reported dispositions the filing shows beneficial ownership levels of 144,508 and 144,115 shares for the two reported lines. The filing states the transactions were automated under the 10b5-1 plan and offers to provide breakdowns of the number of shares sold at each price on request.

Positive

• Trades executed under a Rule 10b5-1 plan, indicating pre-planned disposals and reducing concerns about opportunistic trading based on nonpublic information
• Filing provides weighted-average prices and price ranges and offers to supply per-price execution details on request, supporting transparency

Negative

• Insider disposed of 598 shares (205 and 393 shares), which reduces the reporting person's direct ownership as shown in the post-transaction balances
• Form 4 does not disclose the precise per-trade share counts at each price within the reported ranges; the filer only offers to provide that breakdown on request

Insights

Securities Analyst

TL;DR: Insider sales were executed under a Rule 10b5-1 plan; quantities and weighted-average prices disclosed, suggesting pre-planned disposals.

The reporting person, identified as the CFO, sold 205 and 393 shares in automated transactions under a 10b5-1 trading plan adopted at least 90 days earlier. The filing provides weighted-average prices and ranges for the multiple trades, and reports post-transaction beneficial ownership balances. From a disclosure and governance standpoint, the use of a pre-existing 10b5-1 plan reduces the likelihood that these trades were based on nonpublic information. The volumes disclosed are small relative to typical market-cap insider considerations and are documented with footnotes offering further granular price breakdowns on request.

Corporate Governance Expert

TL;DR: The transactions follow a documented plan, which aligns with best-practice insider trading controls; filing includes standard explanatory footnotes.

The Form 4 indicates the trades were made pursuant to a Rule 10b5-1 plan, an affirmative defense mechanism commonly used to structure insider sales. The filer commits to provide detailed per-price execution information upon request, increasing transparency. The reported post-sale beneficial ownership figures are provided for each line, and no derivative transactions or other material events are disclosed on this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Miln James

(Last) (First) (Middle)

C/O XOMETRY, INC.

6116 EXECUTIVE BLVD, SUITE 800

(Street)

NORTH BETHESDA MD 20852

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Xometry, Inc. [ XMTR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/02/2025		S(1)		205	D	$49.7241(2)	144,508	D
Class A Common Stock	09/02/2025		S(1)		393	D	$50.5207(3)	144,115	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.17 to $49.97, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (2) and (3) to this Form 4.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.195 to $51.11, inclusive.

Remarks:

	/s/ Kristie Scott, Attorney-in-Fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Xometry CFO James Miln report on Form 4 (XMTR)?

The CFO reported selling a total of 598 Class A shares under a Rule 10b5-1 trading plan, with weighted-average prices of $49.7241 and $50.5207.

Were the sales by the insider pre-planned or discretionary?

The filing states the sales were effected automatically pursuant to a Rule 10b5-1 trading plan adopted at least 90 days before the trades.

How many shares did the reporting person own after the reported transactions?

The Form 4 lists post-transaction beneficial ownership figures of 144,508 and 144,115 shares for the two reported lines.

Are detailed per-trade execution prices provided in the filing?

The filing provides weighted-average prices and price ranges for the transactions and offers to provide full per-price breakdowns on request.

Does this Form 4 report any derivative transactions or option exercises?

No. Table II for derivative securities contains no reported transactions; only non-derivative Class A common stock sales are reported.